Clinical Trial

Hyaluronidase Enzymes and Local Anesthesia

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated May 20, 2025 (before its estimated August 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
* For both groups, local anaesthesia will be administered by one single surgeon and the extraction will be performed by another single surgeon across all subjects. The surgeon performing the extraction will be blinded with regard to the local anaesthesia technique used in this study * A buccal infiltration injection of 1.5 ml of 4% articaine with 1:100,000 adrenaline (Septocaine, Septodont, New Castle, Del.) plus 1.5 ml of hyaluronidase enzyme (7.5IU/1ml) will be used in the study group while use 4% articaine with 1:100,000 adrenaline (Septocaine, Septodont, New Castle, Del.)only in traditional inferior alveolar nerve block in the control group * In study and control groups, VAS (visual analogue scale=is an unmarked, continuous, horizontal,100-mm line, anchored by the end points of "no pain" on the left and "worst pain" on the right ) will be used to evaluate the pain levels of the patients associated with the injection and during extraction
Trial Details
NCT Number NCT06980363
Lead Sponsor Fayoum University
Conditions Local Infiltration
Enrollment 20 participants
Start Date 2025-06-01
Primary Completion 2025-08-01 (estimated)
Study Completion 2025-08-27 (estimated)
Updated on ClinicalTrials.gov 2025-05-20